Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.22.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 2,000 $ 616,000 $ (238,000) $ 380,000
Balance (in Shares) at Dec. 31, 2019 1,643,006      
Issuances of common stock, net of issuance costs $ 1,000 1,369,000 0 1,370,000
Issuances of common stock, net of issuance costs (in shares) 757,786      
Issuance of common stock for acquisition $ 0 375,000   375,000
Issuance of common stock for acquisition (in shares) 267,858      
Restricted stock vesting $ 0 0 0 0
Restricted stock vesting (in shares) 169,397      
Warrants issued for equity raising costs $ 0 (65,000) 0 (65,000)
Beneficial conversion and warrant features of convertible debt 0 43,000 0 43,000
Share-based compensation 0 232,000 0 232,000
Net loss 0 0 (2,264,000) (2,264,000)
Balance at Dec. 31, 2020 $ 3,000 2,570,000 (2,502,000) 71,000
Balance (in Shares) at Dec. 31, 2020 2,838,047      
Issuances of common stock, net of issuance costs $ 3,000 13,468,000   13,471,000
Issuances of common stock, net of issuance costs (in shares) 2,686,800      
Restricted stock vesting   61,000   $ 61,000
Restricted stock vesting (in shares) 39,524     39,924
Beneficial conversion and warrant features of convertible debt   2,587,000   $ 2,587,000
Exercise of stock options (in shares) 7,183      
Share-based compensation   223,000   223,000
Derivative liability - COVA   (18,000)   (18,000)
Share adjustment for stock split rounding $ 680      
Net loss     (4,310,000) (4,310,000)
Balance at Dec. 31, 2021 $ 6,000 $ 18,891,000 $ (6,812,000) $ 12,085,000
Balance (in Shares) at Dec. 31, 2021 5,572,234